综合性网络药理学和多组学揭示了异胺酸在败血症中的多目标机制
Ying Chen1,2, Danlei Weng1, Wei Shi1
1Emergency Medicine Clinical Research Center, Beijing Key Laboratory of Cardiopulmonar Cerebral Resuscitation, Beijing Chaoyang Hospital, Affiliated to Capital Medical University, Beijing, 100020, China.
Scientific reports
|July 31, 2025
概括
安尼索达胺酸 (Ani HBr) 通过向超炎症期间的ELANE和增强免疫反应的CCL5来治疗败血症,显示出有希望的结果. 这提供了一个特定阶段的免疫疗法方法.
科学领域:
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
- 计算生物学 计算生物学
背景情况:
- 败血症的治疗是具有挑战性的,因为它的高炎症和免疫抑制阶段.
- 安尼索达胺酸 (Ani HBr) 降低了败血症死亡率,但其机制尚不清楚.
研究的目的:
- 使用综合方法阐明血症中Ani HBr的多目标机制.
- 为了确定关键的目标和途径调节的Ani HBr为特定阶段的败血症治疗.
主要方法:
- 综合网络药理学,机器学习,免疫分析,分子模拟和单细胞转录组学.
- 采用了蛋白质与蛋白质相互作用网络,生存建模和分子对接.
- 对ELANE和CCL5表达的分析与败血症阶段和患者结局有关.
主要成果:
- 确定ELANE和CCL5是败血症进展的核心调节剂.
- 亚尼HBr抑制了ELANE驱动的中性粒细胞细胞外陷 (NET) 的形成,并增强了CCL5介导的细胞毒性T细胞招募.
- 分子模拟证实了Ani HBr与ELANE的直接结合以及与CCL5.5的稳定相互作用.
- 单细胞分析显示了ELANE和CCL5.5的特定阶段表达模式.
结论:
- 亚尼HBr作为一个阶段定制的败血症治疗药物,通过ELANE抑制早期的超炎症,并通过CCL5调节保留后来的免疫功能.
- 开发的ELANE/CCL5预后模型为精密免疫治疗败血症提供了基础.
相关概念视频
Combined Effects of Drugs: Synergism
4.8K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
4.8K
Gene Regulation in Microbial Communities: Quorum Sensing
93
Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...
93
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
510
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
510
Adrenergic Agonists: Indirect-Acting Agents
1.8K
Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
1.8K
Combined Effects of Drugs: Antagonism
9.3K
The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
9.3K
Drug-Receptor Interaction: Agonist
2.8K
Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
2.8K


